Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 3 medicines
HSA · 3 medicines
TFDA · 3 medicines
FDA · 2 medicines
Anvisa · 1 medicine
EMA · 1 medicine
SFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
23 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Erdafitinib | United States | tablet | Tentative approval | Natco Pharma LTD | |
| Balversa | United States | 3MG, 4MG, 5MG | tablet | Marketed | Janssen Biotech |
| Balversa | European Union | Authorised | Janssen-Cilag International N.V. | ||
| Balversa 3 MG Comprimidos Recubiertos con Pelicula | Spain | 3 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Balversa 4 MG Comprimidos Recubiertos con Pelicula | Spain | 4 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Balversa 5 MG Comprimidos Recubiertos con Pelicula | Spain | 5 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Erfandel | Brazil | Authorised | Janssen-Cilag Farmacêutica Ltda | ||
| Balversa | Italy | Compressa rivestita con film | Authorised | Janssen-Cilag International N.V. | |
| Balversa 3 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa 4 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa 5 mg filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Balversa | Canada | 4 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 3 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 5 MG | Tablet | Marketed | Janssen INC |
| Balversa | Canada | 4 MG | Tablet | Authorised | Janssen INC |
| Balversa film-coated tablets 3mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa Film-Coated Tablets 3MG | Singapore | 3.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa Film-Coated Tablets 4MG | Singapore | 4.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa film-coated tablets 4mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa film-coated tablets 5mg | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Balversa Film-Coated Tablets 5MG | Singapore | 5.00 mg | tablet, film coated | Authorised | Johnson & Johnson International (Singapore) Pte LTD |
| Balversa | Croatia | Marketed | |||
| Balversa | Saudi Arabia | Authorised | Janssen-Cilag SPA |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
